Close

BridgeBio Pharma and Brown University Announce Partnership to Drive the Advancement of Academic Innovations in Genetically Driven Diseases into Potential Therapeutics for Patients

Go back to BridgeBio Pharma and Brown University Announce Partnership to Drive the Advancement of Academic Innovations in Genetically Driven Diseases into Potential Therapeutics for Patients
(NASDAQ: BBIO) Delayed: 24.33 -0.7 (2.8%)
Previous Close $25.03    52 Week High
Open $24.42    52 Week Low
Day High $24.51    P/E N/A 
Day Low $23.68    EPS
Volume 1,759,617